InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Shahidi Javad. Director active across 1 company, notably Centessa Pharmaceuticals plc. Cumulatively, 2 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €11k. Activity tracked since 1 July 2022. The latest transaction was disclosed on 30 September 2022 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations